These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2093544)

  • 1. Aluminium interference in the treatment with recombinant human erythropoietin.
    Casati S; Campise M; Ponticelli C
    Contrib Nephrol; 1990; 87():87-94. PubMed ID: 2093544
    [No Abstract]   [Full Text] [Related]  

  • 2. rhEPO treatment of anemia in uremic patients.
    Bommer J; Barth HP; Schwöbel B
    Contrib Nephrol; 1990; 87():59-67. PubMed ID: 2093542
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy.
    Yaqoob M; Ahmad R; McClelland P; Shivakumar KA; Sallomi DF; Fahal IH; Roberts NB; Helliwell T
    Postgrad Med J; 1993 Feb; 69(808):124-8. PubMed ID: 8506193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminium interference in the treatment of haemodialysis patients with recombinant human erythropoietin.
    Casati S; Castelnovo C; Campise M; Ponticelli C
    Nephrol Dial Transplant; 1990; 5(6):441-3. PubMed ID: 2122321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of uraemic anaemia with recombinant human erythropoietin.
    Ponticelli C; Casati S; Campise M
    Adv Exp Med Biol; 1989; 260():53-9. PubMed ID: 2696371
    [No Abstract]   [Full Text] [Related]  

  • 6. Correction of anaemia with recombinant human erythropoietin.
    Ponticelli C; Casati S
    Nephron; 1989; 52(3):201-8. PubMed ID: 2662045
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant human erythropoietin therapy. Part I: clinical issues.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):1-34. PubMed ID: 2928605
    [No Abstract]   [Full Text] [Related]  

  • 8. Arterial hypertension in uraemic patients treated with erythropoietin.
    Kokot F; Wiecek A
    Nephron; 1995; 71(2):127-32. PubMed ID: 8569941
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment.
    Donnelly SM; Smith EK
    Am J Kidney Dis; 1990 Nov; 16(5):487-90. PubMed ID: 2239943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery optimization through Bayesian networks.
    Bellazzi R
    Proc Annu Symp Comput Appl Med Care; 1992; ():572-8. PubMed ID: 1482938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of rHuEPO in treatment of uremic anemia prior to end-stage renal disease.
    Koene RA; Frenken LA
    Kidney Int Suppl; 1992 Oct; 38():S142-7. PubMed ID: 1405365
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythropoietin resistance].
    Branger B
    Nephrologie; 2002; 23(1):3-5. PubMed ID: 11887576
    [No Abstract]   [Full Text] [Related]  

  • 14. Stable renal function and benign course in azotemic diabetics treated with erythropoietin for one year.
    Brown CD; Friedman EA
    Contrib Nephrol; 1991; 88():182-9; discussion 190-1. PubMed ID: 2040181
    [No Abstract]   [Full Text] [Related]  

  • 15. [Erythropoietin: its biological properties and clinical use].
    Ermolenko VM; Nikolaev AIu
    Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Erythropoietin, aluminum and renal anemia].
    Schaefer M; Heidland A
    Dtsch Med Wochenschr; 1990 Jun; 115(22):878-9. PubMed ID: 2347300
    [No Abstract]   [Full Text] [Related]  

  • 17. Adynamic bone disease, anaemia, resistance to erythropoietin and iron-aluminium interaction.
    Drüeke TB
    Nephrol Dial Transplant; 1993; 8 Suppl 1():12-6. PubMed ID: 8389015
    [No Abstract]   [Full Text] [Related]  

  • 18. A pharmacodynamic model of erythropoietin therapy for uremic anemia.
    Uehlinger DE; Gotch FA; Sheiner LB
    Clin Pharmacol Ther; 1992 Jan; 51(1):76-89. PubMed ID: 1732079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin in chemotherapy-associated anemia.
    Cascinu S; Catalano G; Cellerino R
    Cancer Treat Rev; 1996 Nov; 21(6):553-64. PubMed ID: 8599805
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma.
    Zwaginga JJ; IJsseldijk MJ; de Groot PG; Kooistra M; Vos J; van Es A; Koomans HA; Struyvenberg A; Sixma JJ
    Thromb Haemost; 1991 Dec; 66(6):638-47. PubMed ID: 1665596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.